5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule peptide classified as an NNMT inhibitor meaning it blocks the activity of the enzyme nicotinamide N-methyltransferase (NNMT), which plays a key role in cellular energy metabolism , fat storage , and aging
De novo-designed transmembrane domains tune engineered receptor functions
Possible side effects include injection site pain or redness, mild diarrhea, nausea, itching, headache, or dizziness
Step 1: Get a proper diagnosis
Presented for research literature review only Maes RF et al
Additional research has focused on the relationship between NNMT activity and nicotinamide metabolism, methyl donor utilization, and cellular signaling networks associated with energy balance